| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |